Researchers develop novel platform to improve immunotherapy



Researchers develop novel platform to improve immunotherapy

Recent advances in immunotherapy for cancer have stimulated a plethora of studies aimed at developing T cells and Natural Killer (NK) cells in-vitro from pluripotent stem cells. Researchers have discovered a novel pathway based on Notch stimulation very early during the in-vitro differentiation that robustly support the emergence of T and NK cells from human induced Pluripotent Stem Cells (iPSC).

Materials provided by Boston University School of Medicine. Note: Content may be edited for style and length.




Source link aaaaa

Related posts

18th March 2023

New combination of drugs works together to reduce lung tumors in mice

Read more
17th March 2023

Study offers a potential strategy to improve T cell therapy in solid tumors

Read more
17th March 2023

Researchers chart a course for understanding, preventing, and treating young-onset colorectal cancer

Read more